1 Matherly, L. H. & Goldman, D. Membrane transport of folates. Vitamins and Hormones - Advances in Research and Applications, Vol 6666, 403-456, doi:10.1016/s0083-6729(03)01012-4 (2003).
2 Leamon, C. P. & Low, P. S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A88, 5572-5576, doi:10.1073/pnas.88.13.5572 (1991).
3 Antony, A. C. Folate receptors. Annual Review of Nutrition16, 501-521, doi:10.1146/annurev.nu.16.070196.002441 (1996).
4 Rothberg, K. G., Ying, Y. S., Kolhouse, J. F., Kamen, B. A. & Anderson, R. G. W. The glycophospholipid-linkes folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. Journal of Cell Biology110, 637-649, doi:10.1083/jcb.110.3.637 (1990).
5 Elnakat, H. & Ratnam, M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Advanced Drug Delivery Reviews56, 1067-1084, doi:10.1016/j.addr.2004.01.001 (2004).
6 Sabharanjak, S. & Mayor, S. Folate receptor endocytosis and trafficking. Advanced Drug Delivery Reviews56, 1099-1109, doi:10.1016/j.addr.2004.01.010 (2004).
7 Low, P. S. & Antony, A. C. Folate receptor-targeted drugs for cancer and inflammatory diseases - Preface. Advanced Drug Delivery Reviews56, 1055-1058, doi:10.1016/j.addr.2004.02.003 (2004).
8 Leamon, C. P. & Low, P. S. Membrane folate-binding proteins are responsible for folate protein conjugate endocytosis into cultured-cells. Biochemical Journal291, 855-860, doi:10.1042/bj2910855 (1993).
9 Paulos, C. M., Turk, M. J., Breur, G. J. & Low, P. S. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Advanced Drug Delivery Reviews56, 1205-1217, doi:10.1016/j.addr.2004.01.012 (2004).
10 Ke, C. Y., Mathias, C. J. & Green, M. A. Folate-receptor-targeted radionuclide imaging agents. Advanced Drug Delivery Reviews56, 1143-1160, doi:10.1016/j.addr.2004.01.004 (2004).
11 Leamon, C. P. & Reddy, J. A. Folate-targeted chemotherapy. Advanced Drug Delivery Reviews56, 1127-1141, doi:10.1016/j.addr.2004.01.009 (2004).
12 Reddy, J. A. & Low, P. S. Folate-mediated targeting of therapeutic and imaging agents to cancers. Critical Reviews in Therapeutic Drug Carrier Systems15, 587-627 (1998).
13 Leamon, C. P. & Low, P. S. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discovery Today6, 44-51, doi:10.1016/s1359-6446(00)01594-4 (2001).
14 Elwood, P. C. Molecular-cloning and characterization of the human folate-binding protein CDNA from placenta and malignant-tissue culture (KB) cells. Journal of Biological Chemistry264, 14893-14901 (1989).
15 Ratnam, M., Marquardt, H., Duhring, J. L. & Freisheim, J. H. Homologous membran folate binding-proteins in human-placenta - cloning and sequence of a CDNA. Biochemistry28, 8249-8254, doi:10.1021/bi00446a042 (1989).
16 Shen, F., Ross, J. F., Wang, X. & Ratnam, M. Identification of a novel folate receptor, a truncated receptor, and receptor-type-beta in hematopoietic-cells - CDNA cloning, expression, immunoreactivity, and tissue-specificity. Biochemistry33, 1209-1215, doi:10.1021/bi00171a021 (1994).
17 Spiegelstein, O., Eudy, J. D. & Finnell, R. H. Identification of two putative novel folate receptor genes in humans and mouse. Gene258, 117-125, doi:10.1016/s0378-1119(00)00418-2 (2000).
18 Bianchi, E., Doe, B., Goulding, D. & Wright, G. J. Juno is the egg Izumo receptor and is essential for mammalian fertilization. Nature508, 483-487, doi:10.1038/nature13203 (2014).
19 Ross, J. F., Chaudhuri, P. K. & Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in-vivo and in established cell-lines - physiological and clinical implications. Cancer73, 2432-2443, doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s (1994).
20 Weitman, S. D. et al. Cellular-localization of the folate receptor - potential role in drug toxicity and folate homeostasis. Cancer Research52, 6708-6711 (1992).
21 Garinchesa, P. et al. Trophoblast and ovarian-cancer antigen-LK-26 - sensitivity and specificity in immunopathology and molecular-identification as a folate-binding protein. American Journal of Pathology142, 557-567 (1993).
22 Leamon, C. P. & Low, P. S. Cytotoxicity of Momordin-folate conjugates in cultured human-cells. Journal of Biological Chemistry267, 24966-24971 (1992).
23 Atkinson, S. F., Bettinger, T., Seymour, L. W., Behr, J. P. & Ward, C. M. Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. Journal of Biological Chemistry276, 27930-27935, doi:10.1074/jbc.M102825200 (2001).
24 Steinberg, G. & Borch, R. F. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents. Journal of Medicinal Chemistry44, 69-73, doi:10.1021/jm000306g (2001).
25 Ladino, C. A., Chari, R. V. J., Bourret, L. A., Kedersha, N. L. & Goldmacher, V. S. Folate-maytansinoids: Target-selective drugs of low molecular weight. International Journal of Cancer73, 859-864 (1997).
26 Wiener, E. C., Konda, S., Shadron, A., Brechbiel, M. & Gansow, O. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Investigative Radiology32, 748-754, doi:10.1097/00004424-199712000-00005 (1997).
27 Reddy, J. A. & Low, P. S. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. Journal of Controlled Release64, 27-37 (2000).
28 Douglas, J. T. et al. Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnology14, 1574-1578, doi:10.1038/nbt1196-1574 (1996).
29 Leamon, C. P., Weigl, D. & Hendren, R. W. Folate copolymer-mediated transfection of cultured cells. Bioconjugate Chemistry10, 947-957, doi:10.1021/bc990066n (1999).
30 Lee, R. J. & Huang, L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. Journal of Biological Chemistry271, 8481-8487, doi:10.1074/jbc.271.14.8481 (1996).
31 Xu, L. A., Pirollo, K. F., Tang, W. H., Rait, A. & Chang, E. H. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Human Gene Therapy10, 2941-2952, doi:10.1089/10430349950016357 (1999).
32 Zhao, X. B. B. & Lee, R. J. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Advanced Drug Delivery Reviews56, 1193-1204, doi:10.1016/j.addr.2004.01.005 (2004).
33 Nyanguile, O. et al. Synthesis of adenoviral targeting molecules by intein-mediated protein ligation. Gene Therapy10, 1362-1369, doi:10.1038/sj.gt.3301989 (2003).
34 Reddy, J. A., Clapp, D. W. & Low, P. S. Retargeting of viral vectors to the folate receptor endocytic pathway. Journal of Controlled Release74, 77-82 (2001).
35 Citro, G., Szczylik, C., Ginobbi, P., Zupi, G. & Calabretta, B. Inhibition of leukemia-cell proliferation by folic-acid polylysine-mediated introduction of C-MYB antisense oligodeoxynuvleotidesinto HL-60cells. British Journal of Cancer69, 463-467, doi:10.1038/bjc.1994.84 (1994).
36 Li, S., Deshmukh, H. M. & Huang, L. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells. Pharmaceutical Research15, 1540-1545, doi:10.1023/a:1011946915209 (1998).
37 Liu, J. Q., Kolar, C., Lawson, T. A. & Gmeiner, W. H. Targeted drug delivery to chemoresistant cells: Folic acid derivatization of FdUMP 10 enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells. Journal of Organic Chemistry66, 5655-5663, doi:10.1021/jo005757n (2001).
38 Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G. & Low, P. S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth-factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene-glycol. Proceedings of the National Academy of Sciences of the United States of America92, 3318-3322, doi:10.1073/pnas.92.8.3318 (1995).
39 Leopold, L. H., Shore, S. K., Newkirk, T. A., Reddy, R. M. V. & Reddy, E. P. Multiunit ribozyme-mediated cleavage of BCR-ABL messenger-RNA in myeloid leukemias. Blood85, 2162-2170, doi:10.1182/blood.V85.8.2162.bloodjournal8582162 (1995).
40 Leopold, L. H., Shore, S. K. & Reddy, E. P. Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia. Leukemia & Lymphoma22, 365-373, doi:10.3109/10428199609054774 (1996).
41 Guo, W. J., Hinkle, G. H. & Lee, R. J. Tc-99m-HYNIC-folate: A novel receptor-based targeted radiopharmaceutical for tumor imaging. Journal of Nuclear Medicine40, 1563-1569 (1999).
42 Wang, S., Lee, R. J., Mathias, C. J., Green, M. A. & Low, P. S. Synthesis, purification, and tumor cell uptake of Ga-67-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chemistry7, 56-62, doi:10.1021/bc9500709 (1996).
43 Leamon, C. P. et al. Synthesis and biological evaluation of EC20: A new folate-derived, Tc-99m-based radiopharmaceutical. Bioconjugate Chemistry13, 1200-1210, doi:10.1021/bc0200430 (2002).
44 Wang, S. et al. Design and synthesis of In-111 DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjugate Chemistry8, 673-679, doi:10.1021/bc9701297 (1997).
45 Mathias, C. J., Wang, S., Low, P. S., Waters, D. J. & Green, M. A. Receptor-mediated targeting of Ga-67-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts. Nuclear Medicine and Biology26, 23-25, doi:10.1016/s0969-8051(98)00076-6 (1999).
46 Pan, X. Q. et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood100, 594-602, doi:10.1182/blood.V100.2.594 (2002).
47 Anderson, K. E., Eliot, L. A., Stevenson, B. R. & Rogers, J. A. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form. Pharmaceutical Research18, 316-322, doi:10.1023/a:1011002913601 (2001).
48 Gabizon, A., Shmeeda, H., Horowitz, A. T. & Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Advanced Drug Delivery Reviews56, 1177-1192, doi:10.1016/j.addr.2004.01.011 (2004).
49 Shukla, S. et al. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjugate Chemistry14, 158-167, doi:10.1021/bc025586o (2003).
50 Sudimack, J. J. et al. Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharmaceutical Research19, 1502-1508, doi:10.1023/a:1020408716807 (2002).
51 Roy, E. J., Gawlick, U., Orr, B. A. & Kranz, D. M. Folate-mediated targeting of T cells to tumors. Advanced Drug Delivery Reviews56, 1219-1231, doi:10.1016/j.addr.2004.01.006 (2004).
52 Lu, Y. J., Sega, E., Leamon, C. P. & Low, P. S. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Advanced Drug Delivery Reviews56, 1161-1176, doi:10.1016/j.addr.2004.01.009 (2004).
53 Lu, Y. J. & Low, P. S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunology Immunotherapy51, 153-162, doi:10.1007/s00262-002-0266-6 (2002).
54 Lu, J. Y., Hu, G. X., Wang, X. Q., Wu, M. & Liu, J. Cloning and characterization of a novel gene EC97 associated with human esophageal squamous cell carcinoma. International Journal of Molecular Medicine11, 243-247 (2003).
55 Cho, B. K., Roy, E. J., Patrick, T. A. & Kranz, D. M. Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconjugate Chemistry8, 338-346, doi:10.1021/bc9700244 (1997).
56 Kranz, D. M., Patrick, T. A., Brigle, K. E., Spinella, M. J. & Roy, E. J. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor-cells for lysis. Proceedings of the National Academy of Sciences of the United States of America92, 9057-9061, doi:10.1073/pnas.92.20.9057 (1995).
57 Lu, J. Y., Lowe, D. A., Kennedy, M. D. & Low, P. S. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. Journal of Drug Targeting7, 43-53, doi:10.3109/10611869909085491 (1999).
58 Quintana, A. et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharmaceutical Research19, 1310-1316, doi:10.1023/a:1020398624602 (2002).
59 Dube, D., Francis, M., Leroux, J. C. & Winnik, F. M. Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Bioconjugate Chemistry13, 685-692, doi:10.1021/bc010084g (2002).
60 Kono, K., Liu, M. J. & Frechet, J. M. J. Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chemistry10, 1115-1121, doi:10.1021/bc990082k (1999).
61 Caliceti, P. et al. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery. Bioconjugate Chemistry14, 899-908, doi:10.1021/bc034080i (2003).
62 Stevens, P. J. & Lee, R. J. A folate receptor-targeted tinulsion formulation for paclitaxel. Anticancer Research23, 4927-4931 (2003).
63 Kennedy, M. D., Jallad, K. N., Thompson, D. H., Ben-Amotz, D. & Low, P. S. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. Journal of Biomedical Optics8, 636-641, doi:10.1117/1.1609453 (2003).
64 Moon, W. K. et al. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjugate Chemistry14, 539-545, doi:10.1021/bc0340114 (2003).
65 Sandoval, R. M., Kennedy, M. D., Low, P. S. & Molitoris, B. A. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol Cell Physiol287, C517-526, doi:10.1152/ajpcell.00006.2004 (2004).
66 ClinicalTrials.gov. OTL38 Injection for intraoperative imaging of folate receptor positive lung nodules, 2019).
67 Andres, A. Measuring Academic Research: How to undertake a Bibliometric Study. (Chandos Publishing, 2009).
68 Kotepui, M., Wannaiampikul, S., Chupeerach, C. & Duangmano, S. A Bibliometric Analysis of Diets and Breast Cancer Research. Asian Pacific Journal of Cancer Prevention15, 7625-7628, doi:10.7314/apjcp.2014.15.18.7625 (2014).
69 Analytics, C. Web of Science: trust the difference, <https://clarivate.com/products/web-of-science/> (2019).
70 University, L. VOSviewer: visualizing scientific landscapes, <https://www.vosviewer.com/> (2019).
71 Viana, J. et al. Remote Sensing in Human Health: A 10-Year Bibliometric Analysis. Remote Sensing9, doi:10.3390/rs9121225 (2017).
72 Romero, L. & Portillo-Salido, E. Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis. Frontiers in Pharmacology10, doi:10.3389/fphar.2019.00564 (2019).
73 Olsen, D. & Jã¸Rgensen, J. T. S. Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects. Frontiers in Oncology4, doi:10.3389/fonc.2014.00105 (2014).
74 Fernández, M., Javaid, F. & Chudasama, V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chemical Science9, 790-810, doi:10.1039/c7sc04004k (2018).
75 van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med17, 1315-1319, doi:10.1038/nm.2472 (2011).
76 Blümel, C. & Schniedermann, A. Studying review articles in scientometrics and beyond: a research agenda. Scientometrics124, 711-728, doi:10.1007/s11192-020-03431-7 (2020).
77 Nguyen, T. V., Ho-Le, T. P. & Le, U. V. International collaboration in scientific research in Vietnam: an analysis of patterns and impact. Scientometrics110, 1035-1051 (2017).
78 Knottnerus, J. A. & Knottnerus, B. J. Let's make the studies within systematic reviews count. The Lancet373, 1605, doi:10.1016/s0140-6736(09)60906-5 (2009).
79 Ketcham, C. M. & Crawford, J. M. The impact of review articles. Laboratory Investigation87, 1174-1185, doi:10.1038/labinvest.3700688 (2007).
80 Amaniti, A. et al. Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis. Medicina55, 762, doi:10.3390/medicina55120762 (2019).
81 van der Pol, C. B., McInnes, M. D. F., Petrcich, W., Tunis, A. S. & Hanna, R. Is quality and completeness of reporting of systematic reviews and meta-analyses published in high impact radiology journals associated with citation rates? PloS one10, e0119892, doi:10.1371/journal.pone.0119892 (2015).
82 Hutchins, B. I., Yuan, X., Anderson, J. M. & Santangelo, G. M. Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level. PLoS biology14, e1002541, doi:10.1371/journal.pbio.1002541 (2016).
83 Zyoud, S. e. H., Waring, W. S., Al-Jabi, S. W. & Sweileh, W. M. Global cocaine intoxication research trends during 1975–2015: a bibliometric analysis of Web of Science publications. Substance abuse treatment, prevention and policy12, 6-6, doi:10.1186/s13011-017-0090-9 (2017).
84 Chen, H., Yang, Y., Yang, Y., Jiang, W. & Zhou, J. A bibliometric investigation of life cycle assessment research in the web of science databases. The International Journal of Life Cycle Assessment19, 1674-1685, doi:10.1007/s11367-014-0777-3 (2014).
85 Mansoori, P. 50 years of Iranian clinical, biomedical, and public health research: a bibliometric analysis of the Web of Science Core Collection (1965-2014). Journal of global health8, 020701-020701, doi:10.7189/jogh.08.020701 (2018).